Related Experiment Video
Updated: Aug 7, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore
Joseph W Guarnieri1, Alessia Angelin1, Deborah G Murdock1
1Center for Mitochondrial and Epigenomic Medicine, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Background:
Compared to healthy controls, severe COVID19 patients display increased levels of activated NLRP3-inflammasome (NLRP3-I) and interleukin (IL)-1β. SARS-CoV-2 encodes viroporin proteins E and Orf3a(2-E+2-3a) with homologs to SARS-CoV-1, 1-E+1-3a, which elevate NLRP3-I activation; by an unknown mechanism. Thus, we investigated how 2-E+2-3a activates the NLRP3-I to better understand the pathophysiology of severe COVID-19.
Methods:
We generated a polycistronic expression-vector co-expressing 2-E+2-3a from a single transcript. To elucidate how 2-E+2-3a activates the NLRP3-I, we reconstituted the NLRP3-I in 293T cells and used THP1-derived macrophages to monitor the secretion of mature IL-1β. Mitochondrial physiology was assessed using fluorescent microscopy and plate reader assays, and the release of mitochondrial DNA (mtDNA) was detected from cytosolic-enriched fractions using Real-Time PCR.
Results:
Expression of 2-E+2-3a in 293T cells increased cytosolic Ca++ and elevated mitochondrial Ca++, taken up through the MCUi11-sensitive mitochondrial calcium uniporter. Increased mitochondrial Ca++ stimulated NADH, mitochondrial reactive oxygen species (mROS) production and the release of mtDNA into the cytosol. Expression of 2-E+2-3a in NLRP3-I reconstituted 293T cells and THP1-derived macrophages displayed increased secretion of IL-1β. Increasing mitochondrial antioxidant defenses via treatment with MnTBAP or genetic expression of mCAT abolished 2-E+2-3a elevation of mROS, cytosolic mtDNA levels, and secretion of NLRP3-activated-IL-1β. The 2-E+2-3a-induced release of mtDNA and the secretion of NLRP3-activated-IL-1β were absent in cells lacking mtDNA and blocked in cells treated with the mitochondrial-permeability-pore(mtPTP)-specific inhibitor NIM811.
Conclusion:
Our findings revealed that mROS activates the release of mitochondrial DNA via the NIM811-sensitive mitochondrial-permeability-pore(mtPTP), activating the inflammasome. Hence, interventions targeting mROS and the mtPTP may mitigate the severity of COVID-19 cytokine storms.
Insights
Severe COVID-19 involves elevated NLRP3-inflammasome (NLRP3-I) and IL-1β. SARS-CoV-2 proteins 2-E+2-3a activate NLRP3-I via mitochondrial calcium, mROS, and mtDNA release through the mtPTP.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Severe COVID-19 is associated with increased NLRP3-inflammasome (NLRP3-I) activation and interleukin (IL)-1β levels compared to healthy controls.
- SARS-CoV-2 viroporin proteins 2-E+2-3a are homologous to SARS-CoV-1 proteins and are known to activate NLRP3-I through an uncharacterized mechanism.
Purpose of the Study:
- To investigate the mechanism by which SARS-CoV-2 proteins 2-E+2-3a activate the NLRP3-inflammasome.
- To elucidate the role of mitochondrial dysfunction in COVID-19 pathophysiology.
Main Methods:
- Co-expression of SARS-CoV-2 proteins 2-E+2-3a using a polycistronic vector.
- Reconstitution of the NLRP3-inflammasome in 293T cells and use of THP1-derived macrophages to assess IL-1β secretion.
- Evaluation of mitochondrial physiology, including calcium uptake, reactive oxygen species (mROS) production, and mitochondrial DNA (mtDNA) release.
Main Results:
- Expression of 2-E+2-3a increased cytosolic and mitochondrial calcium levels, stimulating mROS production and mtDNA release into the cytosol.
- 2-E+2-3a expression led to increased IL-1β secretion in NLRP3-I reconstituted cells and macrophages.
- Inhibition of mROS or blocking the mitochondrial-permeability-pore (mtPTP) with NIM811 prevented 2-E+2-3a-induced mtDNA release and IL-1β secretion.
Conclusions:
- Mitochondrial reactive oxygen species (mROS) activate the release of mitochondrial DNA (mtDNA) through the NIM811-sensitive mitochondrial-permeability-pore (mtPTP), subsequently activating the inflammasome.
- Targeting mROS and the mtPTP presents a potential therapeutic strategy to mitigate severe COVID-19 and cytokine storms.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Porin Insertion in the Outer Mitochondrial Membrane
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
The Extrinsic Apoptotic Pathway
Structure of Porins
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...

